20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T40312 | Plasma kallikrein-IN-1 | ||
Plasma kallikrein-IN-1 is a PKK inhibitor with an IC 50 value of 0.5 nM. | |||
T61403 | Plasma kallikrein-IN-3 | ||
Plasma kallikrein-IN-3, a potent inhibitor ( IC 50 : 0.15 μM) of plasma kallikrein, finds application in research related to hereditary angioedema, diabetic macular edema, and diabetic retinopathy [1]. | |||
T72337 | Plasma kallikrein-IN-2 | ||
Plasma kallikrein-IN-2, a potent inhibitor of plasma kallikrein (PKal) with an inhibitory concentration (IC) 50 value of 0.1 nM, is utilized in research targeting hereditary angioedema, diabetic macular edema, and diabet... | |||
T16369 | O-Desmethyl gefitinib | EGFR | |
O-Desmethyl gefitinib inhibits EGFR (IC50: 36 nM in subcellular assays). In human plasma, O-Desmethyl gefitinib is an active metabolite of Gefitinib. The formation of O-desmethyl gefitinib is dependent on the CYP2D6 acti... | |||
T9215 | ELOVL6-IN-2 | Others | |
ELOVL6-IN-2 is a orally active and selective ELOVL6 inhibitor. | |||
T26019 | R59949 | R-59949,R 59949 | Others , PKC |
R59949 is used as a Diacylglycerol kinase (DGK) inhibitor. | |||
T34532 | Sari 59-801 | Sari-59-801 | Others |
Sari 59-801 is a novel, orally effective hypoglycemic compound. | |||
T14984 | CLP257 | Potassium Channel | |
CLP257 is a selective K+-Cl− cotransporter KCC2 activator (EC50: 616 nM) and it is inactive against NKCC1, GABAA receptors, KCC1, KCC3 or KCC4. CLP257 alleviates hypersensitivity in rats with neuropathic painc and it al... | |||
T8235 | L-732138 | Neurokinin receptor | |
L-732138 is a potent and competitive antagonist of neurokinin-1 (NK-1) receptor(IC50 : 2.3 nM) | |||
T11793 | KY-05009 | Wnt/beta-catenin | |
KY-05009 is a chemical compound that effectively suppresses TGF-β1-induced epithelial-to-mesenchymal transition (EMT) in human lung adenocarcinoma cells, reduces TNIK protein expression and the transcriptional activity o... | |||
T1736 | Apixaban | BMS-562247-01 | Factor Xa |
Apixaban (BMS-562247-01) is an orally active inhibitor of coagulation factor Xa with anticoagulant activity. Apixaban directly inhibits factor Xa, thereby interfering with the conversion of prothrombin to thrombin and pr... | |||
TP1158 | Copper tripeptide | GHK-Cu | Others , Endogenous Metabolite |
Copper tripeptide (GHK-Cu) is a naturally occurring copper complex of the tripeptide glycyl-L-histidyl-L-lysine. The tripeptide has strong affinity for copper(II) and was first isolated from human plasma. It can be found... | |||
T16075 | (Rac)-Idroxioleic acid | 2-Hydroxyoleic acid,2-OHOA,Minerval | Apoptosis |
(Rac)-Idroxioleic acid (2-Hydroxyoleic acid) is a fatty acid amide hydrolase inhibitor with anti-tumor effect. It binds to the plasma membrane and alters lipid organization. | |||
T12146 | N-Desmethyl-Apalutamide | N-Desmethyl Apalutamide | P450 , Androgen Receptor |
N-Desmethyl-Apalutamide is a less potent antagonist of the androgen receptor, is an active Apalutamide metabolite. | |||
T2499 | Torcetrapib | CP-529414 | CETP |
Torcetrapib (CP-529414) is a cholesteryl ester transfer protein (CETP) inhibitor that reduces the heterotypic transfer of cholesteryl ester from HDL to LDL and/or VLDL. Torcetrapib failed in phase III trials due to exces... | |||
T10353 | APX-115 free base | Ewha-18278 free base | NADPH-oxidase , NADPH |
APX-115 free base (Ewha-18278 free base) (Ewha-18278 free base) is a potent, orally active pan NADPH oxidase (Nox) inhibitor (Kis: 1.08 μM, 0.57 μM, and 0.63 μM for Nox1, Nox2, and Nox4). APX-115 effectively prevents kid... | |||
T12372 | PAT-505 | EGFR | |
PAT-505 is an orally available, selective and potent inhibitor of autologous epidermal growth factor (IC50 2 nM in Hep3B cells, 9.7 nM in human blood, 62 nM in mouse plasma). | |||
TP2124L | Somatostatin 1-28 acetate | Somatostatin 1-28 acetate(74315-46-1 Free base) | Somatostatin |
Somatostatin 1-28 acetate circulates in human plasma. Approximately 46% of the total somatostatin-like immunoreactivity in plasma is due to Somatostatin 1-28 acetate. | |||
T60104 | Mycophenolic acid-β-D-glucuronide solution | Others | |
Mycophenolic acid glucuronide is the glucuronide metabolite of mycophenolic acid in human plasma. | |||
T6999 | Teneligliptin hydrobromide | Teneligliptin hydrobromide anhydrous,MP-513 (hydrobromide) | Others , Proteasome , DPP-4 |
Teneligliptin hydrobromide (MP-513 (hydrobromide)) is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor; competitively inhibited human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50 ... |